Australia's largest stock trading and investment forum Australia's #1 stock forum

BLT

0.00%

2.6¢ benitec biopharma limited

And on the positive side..., page-2

First 2 Last

Share
Profile

Follow
chewiee

169 Posts.

25/06/14

13:37

Post #: 13569703
Share

Originally posted by Hoyland ↑

We on this thread have often referred to the vast amount of research that is done around the world which supports Benitec's technology and potentially broadens is licensing opportunities. This latest research is a classic example of this this claim. The paper discusses the use of gene therapy to treat AMD. In so doing it completely validates Benitec's AMD program, with in vivo evidence in support of the "proof of concept" for Benitec's program. It now remains to be seen how much of this work we can build on and incorporate into our own pre-clinical studies. Potentially this work could shortcut our development time. I think our team should at least make contact with the author and have a conversation.

In conclusion, these highly promising data clearly demonstrate that viral-encoded RNAi effector molecules can be used for the inhibition of neovascularization and will, in combination with the growing interest of applying DNA- or RNA-based technologies in the clinic, undoubtedly contribute to the development of efficacious long-term gene therapy treatment of intraocular neovascular diseases.

Expand

Excellent Hoy, as always. On another matter, can u.s. investors buy blt shares on the asx and convert them into bteby ? if so, i see massive buying by the americans sooner or later.

BLT Price at posting: $1.15 Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

RMX

Red Mountain Mining: record gold prices, two projects, two greenstone belts

CBA breaks trading record on strong day for Aussie financials

QML

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

OCC

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

LAM

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

PRU

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

BIT

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

SBW

Shekel Brainweigh investor presentation webinar – the future of retail automation

As Nvidia cools, we're looking to Aussie AI

There are more pages in this discussion • 1 more message in this thread...

First 2 Last

Add BLT (ASX) to my watchlist

And on the positive side..., page-2

Top Stories

Red Mountain Mining: record gold prices, two projects, two greenstone belts

CBA breaks trading record on strong day for Aussie financials

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Shekel Brainweigh investor presentation webinar – the future of retail automation

As Nvidia cools, we're looking to Aussie AI

Featured News